Recombinant human growth hormone secreted from tissue-engineered bioartificial muscle improves left ventricular function in rat with acute myocardial infarction

Chinese Medical Journal

Volumn 122, Issue 19, 2009, Pages 2352-2359

  Rong, Shu Ling ^a   Wang, Yong Jin ^a   Wang, Xiao Lin ^a   Lu, Yong Xin ^b   Chang, Chao ^b   Wang, Feng Zhi ^c   Liu, Qi Yun ^b   Liu, Xiang Yang ^b   Gao, Yan Zhang ^b   Mi, Shao Hua ^b  

^a CHANGZHI MEDICAL COLLEGE   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Gene therapy; Growth hormone; Heart failure; Muscles

Indexed keywords

HUMAN GROWTH HORMONE; RETROVIRUS VECTOR; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSDUCTION; HEART LEFT VENTRICLE FUNCTION; HISTOPATHOLOGY; HORMONE DETERMINATION; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEFT CORONARY ARTERY; MALE; MUSCLE TRANSPLANTATION; MYOBLAST; NONHUMAN; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RAT; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ANIMALS; BIOARTIFICIAL ORGANS; ECHOCARDIOGRAPHY; HEART FAILURE; HUMAN GROWTH HORMONE; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TISSUE ENGINEERING; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT;

EID: 70350613123     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.19.030     Document Type: Article

References (29)

1. McElhinney DB, Colan SD, Moran AM, Wypij D, Lin M, Majzoub JA, et al. Recombinant human growth hormone treatment for dilated cardiomyopathy in children. Pediatrics 2004; 114: e452-e458. (Pubitemid 41529742)
2. Kontoleon PE, Anastasiou-Nana MI, Papapetrou PD, Alexopoulos G, Ktenas V, Rapti AC, et al. Hormonal profile in patients with congestive heart failure. Int J Cardiol 2003; 87: 179-183. (Pubitemid 36135974)
3. Kusano K, Tsutsumi Y, Dean J, Gavin M, Ma H, Silver M, et al. Long-term stable expression of human growth hormone by rAAV promotes myocardial protection post-myocardial infarction. J Mol Cell Cardiol 2007: 42: 390-399. (Pubitemid 46135607)
4. Jayasankar V, Pirolli TJ, Bish LT, Berry MF, Burdick J, Grand T, et al. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy. J Mol Cell Cardiol 2004; 36: 531-538. (Pubitemid 38469943)
5. Rong SL, Lu YX, Liao YH, Wang XL, Wang YJ, Chang C, et al. Effetcs of transplantated myoblasts transfected with human growth hormone gene on improvement of Ventricular function of rats. Chin Med J 2008; 121: 347-354.
6. Melmed S, Jackson I, Kleinberg D, Klibanski A. Current treatment guidelines for acromegaly. J Clin Endocrinol Metab 1998; 83: 2646-12452
7. Fukuda I, Hizuka N, Murakami Y, Itoh E, Yasumoto K, Sata A, et al. Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women's Medical University. Intern Med 2001; 40: 987-992. (Pubitemid 33041137)
8. Vandenburgh H, Del Tatto M, shansky J, Goldstein L, Russell LK, Genes N, et al. Attenuation of skeletal muscle wasting with recombinant human growth hormone secreted from a tissue-engineered bioartificial muscle. Hum Gene Ther 1998; 9: 2555-2564.
9. Ylä-Herttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 2003; 9: 694-701. (Pubitemid 36749218)
10. Gounis MJ, Spiga MG, Graham RM, Wilson A, Haliko S, Lieber BB, et a1. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle. Gene Ther 2005; 12: 762-771.
11. Rong SL, Lu YX, Liao YH, Wang XL, Guo HP, Chang C, et al. Effects of recombinant retroviral vector mediated human insulin like growth factor-1 gene transfection on skeletal muscle growth in rat. Chin Med J 2006; 119: 1991-1998. (Pubitemid 46592057)
12. Shansky J, Del Tatto M, Chromiak J, Vandenburgh HH. A simplified method for tissue engineering skeletal muscle organoids in vitro. In Vitro Cell Dev Biol Anim 1997; 33: 659-661.
13. Ly H, Kawase Y, Yoneyama R, Hajjar RJ. Gene therapy in the treatment of heart failure. Physiology 2007; 22: 81-96.
14. Vinge LE, Raake PW, Koch WJ. Gene therapy in heart failure. Circ Res 2008; 102: 1458-1470.
15. Adriaansen J, Vervoordeldonk MJ, Tak PP. Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes. Rheumatology 2006: 45: 656-668. (Pubitemid 43985333)
16. Lu Y, Shansdy J, Del Tatto M, Ferland P, Wang X, Vandenburgh H. Ricombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis. Circulation 2001; 1004: 594-599. (Pubitemid 32738131)
17. Lu Y, Shansky J, Del Tatto M, Ferland P, McGuire S, Marszalkowski J, et al. Therapeutic potential of implanted tissue-engineered bioartificial musclis delivering recombinant proteins to the sheep heart. Ann N Y Acad Sci 2002; 961: 78-82. (Pubitemid 34721745)
18. Adamopoulos S, Parissis JT, Paraskevaidis I, Karatzas D, Livanis E, Georgiadis M, et al. Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy. Eur Heart J 2003; 24: 2186-2196. (Pubitemid 37522671)
19. Yang R, Bunting S, Gillett N, Clark R, Jin H. Growth hormone improves cardiac performance in experimental heart failure. Circulation 1995; 92: 262-267.
20. Hongo M, Ryoke T, Schoenfeld J, Hunter J, Dalton N, Clark R, et al. Effects of growth hormone on cardiac dysfunction and gene expression in genetic murine dilated cardiomyopathy. Basic Res Cardiol 2000; 95: 431-441. (Pubitemid 32013985)
21. Maison P, Chanso P. Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis. Circulation 2003; 108: 2648-2652. (Pubitemid 37466806)
22. Maison P, Tropeano AI, Macquin-Mavier I, Giustina A, Chanson P. Impact of somatostatin analogs on the heart in acromegaly: a meta analysis. Clin Endocrinol Metab 2007; 92: 1743-1747. (Pubitemid 46997181)
23. Le Corvoisier P, Hittinger L, Chanson P, Montagne O, Macquin-Mavier I, Maison P, et al. Cardiac effects of growth hormone treatment in chronic heart failure: a meta-analysis. J Clin Endocrinol Metab 2007; 92: 180-185. (Pubitemid 46067528)
24. Fazio S, Palmieri EA, Affuso F, Cittadini A, Castellano G, Russo T, et al. Effects of growth hormone on exercise capacity and cardiopulmonary performance in patients with chronic heart failure. Clin Endocrinol Metab 2007; 92: 4218-4223. (Pubitemid 350074734)
25. Gargosky S, Tapanainen P, Rosenfeld R. Administration of growth hormone (GH) but not insulin-like factor-1 (IGF-1), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats. Endocrinology 1994; 134: 2267-2276. (Pubitemid 24978240)
26. Guo XM, Wang HL, Chu HY, Wang X, Qu B, Li Z, et al. High level expression of human factor VIII in mammalian cells after retroviral-mediated gene transfer. Chin Med J 2001; 114: 690-693. (Pubitemid 33664613)
27. Dolnikov A, Wotherspoon S, Millington M, Symonds G. Retrovirus vector production and transduction: modulation by the cell cycle. Gen Virol 2003; 84: 3131-3141. (Pubitemid 37336798)
28. Habu Y, Miyano-Kurosaki N, Kitano M, Endo Y, Yukita M, Ohira S, et al. Inhibition of HIV-1 gene expression by retroviral vector-mediated small-guide RNAs that direct specific RNA cleavage by tRNase ZL. Nucleic Acids Res 2005; 33: 235-243. (Pubitemid 40276945)
29. Powell C, Shansky J, Del Tatto M, Forman DE, Hennessey J, Sullivan K, et al. Tissue-engineered human bioartificial muscles expressing a foreign recombinant protein for gene therapy. Hum Gene Ther 1999; 10: 565-577. (Pubitemid 29131323)